Vukasin Paunovich sold $541k of LFST
Chief Technology Officer at LifeStance Health Group, Inc.. 42,067 shares at an average of $12.87, traded Sep 2, 2026, filed Sep 4, 2026.
Score components
- +15RoleOfficer
- +19Trade size$541k at market
- +5Share of holdings soldSold 17% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-383783, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | SOpen-market sale Common Stock | -42,067 | $12.87 | $541k | 205,379 | 38 d ago |
Related signals
Other insiders at LifeStance Health Group, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | LifeStance Health Group, Inc. | Tpg Gp A, LLC owner | $226M 18,409,705 shares | -19% | |
| 22Weak | LFSTsell LifeStance Health Group, Inc. | Ujjwal Ramtekkar Chief Medical Officer | $49k 9,519 shares | -8% | |
| 30Weak | LFSTsell LifeStance Health Group, Inc. | Ujjwal Ramtekkar Chief Medical Officer | $95k 16,000 shares | -12% | |
| 1Weak | LifeStance Health Group, Inc. | Robert Bessler director | $34k 4,914 shares | -0% | |
| 22Weak | LifeStance Health Group, Inc. | Robert Bessler director | $566k 75,000 shares | -5% | |
| 32Weak | LifeStance Health Group, Inc. | Lisa K Miller See Remarks | $79k 10,540 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.